Clinica de Marly (BOG:MARLY) EBITDA Margin %: 30.93% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Clinica de Marly EBITDA Margin %?

Clinica de Marly BOG:MARLY EBITDA Margin % is 30.93% as of Jun. 2026.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Clinica de Marly's EBITDA for the three months ended in Jun. 2026 was COP36,879 Mil. Clinica de Marly's Revenue for the three months ended in Jun. 2026 was COP119,240 Mil. Therefore, Clinica de Marly's EBITDA margin for the quarter that ended in Jun. 2026 was 30.93%.

Clinica de Marly  (BOG:MARLY) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Clinica de Marly EBITDA Margin % Related Terms

Clinica de Marly EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Clinica de Marly's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinica de Marly EBITDA Margin % Chart

Clinica de Marly Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.26 22.09 22.72 32.09 31.01

Clinica de Marly Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.58 32.60 34.83 31.92 30.93

BOG:MARLY vs SPIN, USNU, GRST: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, Clinica de Marly's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinica de Marly EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clinica de Marly's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Clinica de Marly's EBITDA Margin % falls into.


Clinica de Marly EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Clinica de Marly's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=135162.358/435882.17
=31.01 %

Clinica de Marly's EBITDA Margin % for the quarter that ended in Jun. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=36879.34/119240.37
=30.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 30.93% mean?
Clinica de Marly (BOG:MARLY) has a EBITDA Margin % of 30.93% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Clinica de Marly and its competitors.
Is Clinica de Marly's EBITDA Margin % too high?
Clinica de Marly's current EBITDA Margin % is 30.93%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.18. Clinica de Marly's value of 30.93% is 203.8% above this industry median.
How does Clinica de Marly's EBITDA Margin % compare to SPIN and USNU?
Clinica de Marly's EBITDA Margin % of 30.93% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.18. Clinica de Marly's value of 30.93% is 203.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.18, based on 672 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clinica de Marly's current EBITDA Margin % of 30.93% is 203.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Clinica de Marly and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinica de Marly's current EBITDA Margin % is 30.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica de Marly stock overvalued right now?
Clinica de Marly (BOG:MARLY) has a current EBITDA Margin % of 30.93%. The current EBITDA Margin % is 30.93% and 203.8% above the Healthcare Providers & Services industry median of 10.18. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Clinica de Marly (BOG:MARLY), the current EBITDA Margin % is 30.93% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clinica de Marly Business Description

Address Calle 50 No. 9-67, Bogota, COL
Clinica de Marly SA provides healthcare services in Colombia. Its services includes anesthesia and pain clinic, blood bank, blood densitometry, bone marrow transplant, cardiology, clinic laboratory, dentistry, emergency, and external consultation.